Schimmelpennink Evert B.

CIK 0001713795

President, CEO and SecretaryDirector

Filings

Latest Mar 30, 2026

Issuers covered

Showing

10 of 10

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Schimmelpennink Evert B.. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Schimmelpennink Evert B. has filed

Ticker	Issuer	Filings	Last filed
GRPH	Graphite Bio, Inc.	6	Mar 30, 2026
CTNM	Contineum Therapeutics, Inc.	2	Jun 26, 2025
IBIO	Ibio, Inc.	2	Nov 24, 2025

10 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Mar 30, 2026	GRPHGraphite Bio, Inc.	PPurchase	28,089	$8.9505	$251,411
Jan 6, 2026	GRPHGraphite Bio, Inc.	Holdings only	-	-	-
Nov 24, 2025	IBIOIbio, Inc.	Holdings only	-	-	-
Jun 26, 2025	CTNMContineum Therapeutics, Inc.	Holdings only	-	-	-
Mar 7, 2025	GRPHGraphite Bio, Inc.	MExercise	4,200	$1.04	$4,368
Jan 13, 2025	GRPHGraphite Bio, Inc.	Holdings only	-	-	-
Nov 25, 2024	IBIOIbio, Inc.	Holdings only	-	-	-
Jul 23, 2024	GRPHGraphite Bio, Inc.	MExercise	45,000	$1.04	$46,800
May 29, 2024	CTNMContineum Therapeutics, Inc.	Holdings only	-	-	-
Mar 25, 2024	GRPHGraphite Bio, Inc.	Holdings only	-	-	-

Showing 1-10 of 10

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.